RELATIONSHIP OF WHITE BLOOD CELL COUNTS, HAEMOGLOBIN AND ESR WITH IHD
AbstractObjectives: To find any association of white blood cells, haemoglobin and ESR with ischemic heartdisease in high risk native population. Methodology: The study included 93 male patients withIschemic heart disease, between 40 and 60 years of age; 96 age and gender matched subjects. Allstudy participants were non-diabetics. Complete blood cells count, haemoglobin and ESR levelswere compared between the patient and control groups. Results: Total leukocyte counts along withneutrophils were significantly higher in the test group compared to the control population (p<0.001)and lymphocytes were significantly lower (p<0.001) in the patient group as compared to the controlgroup. Haemoglobin levels were significantly lower (p<0.001) and ESR was higher (p=0.030) in thepatient group as compared to the control group. Conclusion: Although, our findings of the studyvariables extend previous reports, the prevalence and prognostic importance of theses variables inIHD should be assessed in future experimental studies. These parameters could be important inpublic health because they are routinely measured by clinicians and may be helpful to predict the riskof future and secondary ischemic events in a high risk population.Keywords: TLC, DLC, Haemoglobin, ESR, Ischemic Heart Disease
Ounpuu S, Anand S, Yusuf S. The global burden of
cardiovascular disease. Medscape Cardiology. Available from
Jia E, Yang Z, Yuan B, Zang X, Wang R, Zhu T, Wang L, Chen
B, Ma W. Relationship between leukocyte count and
angiographical charateristics of coronary atherosclerosis. Acta
Pharmacologica Sinica 2005;26(9):1057–62.
Sweetnam PM, Thomas HF, Yarnell JW, Baker IA, Elwood PC.
Total and Differential Leukocyte Counts as predictors of
ischemic heart disease: The Caerphilly and Speedwell Studies.
Am J Epidemiol 1997;145:416–21.
Weijenberg MP, Feskens EJ, Kromhout D. White blood cell
count and the risk of coronary heart disease and all-cause
mortality in elderly men. Arterioscler Thromb Vasc
Hansson GK. Inflammation, atherosclerosis and coronary artery
disease. N Engl J Med 2005;352:1685–95.
Madjid M, Awan I, Willerson J T, Casscells S W. Leukocyte
count and coronary heart disease. J Am Coll Cardiol
Zeidman A, Zinaida F, Blecher A, Oster HS, Avrahami Y,
Mittelman M. Anemia as a risk factor for ischemic heart disease.
Dijk JM, Wangge G, van der Graaf Y, Bots ML, Grobbee D.E,
Algra A. Hemoglobin and atherosclerosis in patients with
manifest arterial disease The SMART-Study. Atherosclerosis
Arant CB, Wessel TR, Olson MB, Merz CN, Sopko J, Rogers
WJ, et al. Hemoglobin level is an independent predictor for
adverse cardiovascular outcomes in women undergoing
evaluation for chest pain. J Am Coll Cardiol 2004;43:2009–14.
Natali A, L’ Abbate A, Ferrannini E. Erythrocyte sedimentation
rate, coronary atherosclerosis, and cardiac mortality. Eur Heart J
Danesh J, Collins R, Peto R, Lowe GD. Haematocrit, viscosity,
erythrocyte sedimentation rate: meta-analysis of prospective
studies of coronary heart disease. Eur Heart J 2000;21:515–20.
Erikssen G, Liestol K, Bjornholt JV, Stormorken H, Thaulow E,
Erikssen J. Erythrocyte sedimentation rate: a possible marker of
atherosclerosis and a strong predictro of coronary heart disease
mortality. Eur Heart J 2000;21:1614–20.
Report of the Expert Committee on the Diagnosis and
Classification of Diabetes Mellitus. Diabetes Care
Wheeler JG, Mussolino ME, Gillum RF, Danesh J. Associations
between differential leukocyte count and incident coronary heart
disease: 1764 incident cases from seven prospective studies of
individuals. Eur Heart J 2004;25:1287–92.
Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt
T, Hacke W. Leukocyte count as an independent predictor of
recurrent ischemic events. Stroke 2004;35:1147–52.
Zouridakis EG, Garcia-Moll X, Kaski JC. Usefulness of the
blood lymphocyte count in predicting recurrent instability and
death in patients with unstable angina pectoris. Am J Cardiol
Ommen SR, Gibbons RJ, Hodge DO, Thomas SP. Usefulness of
the lymphocyte concentration as a prognostic marker in coronary
artery disease. Am J Cardiol 1997;79:812–4.
Knoflach M, Kiechl S, Mayr A, Willeit J, Poewe W, Wick G.
Allergic Rhinitis, Asthma, and Atherosclerosis in the Bruneck
and ARMY studies. Arch Intern Med 2005;165:2521–6.
Sarnak M.J, Tighiouart H, Manjunath G, MacLeod B, Griffith J,
Salem D, Levey A.S. Anemia as a risk factor for cardiovascular
disease in the atherosclerosis risk in communities (aric) study. J.
Am. Coll. Cardiol.2002;40:27–33.